UCI School of Medicine Research Insider

October 8, 2024

UC Irvine researchers are first to reveal role of ophthalmic acid in motor function control

A research team from the University of California, Irvine is the first to reveal that a molecule in the brain — ophthalmic acid — unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new therapeutic target for Parkinson’s and other movement diseases.

UC Irvine receives initial $33 million in federal support for vaccine research

Philip Felgner, PhD, professor in residence in the Department of Physiology & Biophysics, and director of UC Irvine’s Adeline Yen Mah Vaccine Center, will lead a multi-institutional pandemic planning effort with this $33 million grant from the National Institute of Allergy and Infectious Diseases.

UCI School of Medicine Research Insider

October 1, 2024

Circadian disruption, gut microbiome changes linked to colorectal cancer progression

Research from the University of California, Irvine has revealed how disruption of the circadian clock, the body’s internal, 24-hour biological pacemaker, may accelerate the progression of colorectal cancer by affecting the gut microbiome and intestinal barrier function.

Two School of Medicine professors ranked Best Female Scientists in the World

Research.com's 2024 ranking of Best Female Scientists in the World included Susan O’Brien, MD, and Hoda Anton-Culver, PhD.

UCI School of Medicine Research Insider

September 24, 2024

UCI School of Medicine Research Insider

September 17, 2024

Dean's News & Events Newsletter | 28th Edition

September 2024

School of Medicine awarded $1.5 million suicide prevention grant

The School of Medicine has received a three-year, $1.5 million Focus Grant from the American Foundation for Suicide Prevention to explore innovative approaches to identifying blood-based biomarkers that may predict suicide risk.